PACBVSPH• 28 Days (Normalized)
PACB vs PH (Pacific Biosciences of California Inc. vs Parker-Hannifin Corporation)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PACB Performance $2.33
+79.23%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
PH Performance $962.56
+1.3%
Parker-Hannifin Corporation
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
+77.93 pts
PACB outperforming by 77.93 percentage points
PACBPH
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PACB PH
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | PACB Price | PACB Gain (%) | PH Price | PH Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $2.33 | +79.23% | $962.56 | +1.30% | +77.93% |
| Oct 08, 2026 | $2.30 | +76.92% | $946.96 | -0.34% | +77.26% |
| Oct 07, 2026 | $2.72 | +109.23% | $952.79 | +0.27% | +108.96% |
| Oct 06, 2026 | $2.70 | +107.69% | $984.91 | +3.65% | +104.04% |
| Oct 05, 2026 | $2.87 | +120.77% | $975.68 | +2.68% | +118.09% |
| Oct 02, 2026 | $2.54 | +95.38% | $972.55 | +2.35% | +93.03% |
| Oct 01, 2026 | $2.51 | +93.08% | $- | - | |
| Sep 30, 2026 | $2.37 | +82.31% | $- | - | |
| Sep 29, 2026 | $1.83 | +40.77% | $964.68 | +1.52% | +39.25% |
| Sep 28, 2026 | $1.71 | +31.54% | $969.55 | +2.03% | +29.51% |
| Sep 25, 2026 | $- | $978.33 | +2.96% | - | |
| Sep 24, 2026 | $1.46 | +11.92% | $974.98 | +2.60% | +9.32% |
| Sep 23, 2026 | $1.41 | +8.46% | $971.21 | +2.21% | +6.25% |
| Sep 22, 2026 | $- | $964.85 | +1.54% | - | |
| Sep 21, 2026 | $1.36 | +4.62% | $958.17 | +0.84% | +3.78% |
Page 1 of 2